Non Metastatic Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting non metastatic clinical trials across 5 countries. Studies span Not Applicable, Phase 2. Top locations include Angers, France, Avignon, France, Blida, Algeria. Updated daily from ClinicalTrials.gov.


Non Metastatic Trials at a Glance

7 actively recruiting trials for non metastatic are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Angers, Avignon, and Blida. Lead sponsors running non metastatic studies include Fondazione del Piemonte per l'Oncologia, Fudan University, and Blida 1 University.

Browse non metastatic trials by phase

Treatments under study

About Non Metastatic Clinical Trials

Looking for clinical trials for Non Metastatic? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Non Metastatic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Non Metastatic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

A Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and Mininvasivity

Rectal AdenocarcinomaNon Metastatic
Fondazione del Piemonte per l'Oncologia200 enrolled1 locationNCT06952101
Recruiting
Phase 2

Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma

Cholangiocarcinoma Non-resectableNon Metastatic
University Hospital, Montpellier40 enrolled7 locationsNCT03364530
Recruiting
Not Applicable

Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for Non-metastatic Colorectal Cancer

Circulating Tumor DNA MethylationNon Metastatic Colorectal Cancer
Fudan University584 enrolled1 locationNCT05904665
Recruiting

Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer

Non Metastatic HER2 Positive Breast Cancer
Blida 1 University70 enrolled1 locationNCT07166185
Recruiting
Not Applicable

Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer Treatment

Breast CancerColorectal, CancerNon Metastatic Cancer
Université de Sherbrooke44 enrolled2 locationsNCT06911970
Recruiting
Not Applicable

Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer

Rectal CancerNon Metastatic Cancer
Institut Sainte Catherine100 enrolled1 locationNCT06536127
Recruiting
Not Applicable

Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer

Non Metastatic Colorectal Cancer
Hospital St. Joseph, Marseille, France100 enrolled2 locationsNCT04938986